CEimpact Podcast

Treatment of MRSA Bacteremia with Clindamycin

October 12, 2021 CEimpact Season 2 Episode 18
CEimpact Podcast
Treatment of MRSA Bacteremia with Clindamycin
Show Notes

For over 50 years, the standard has been that Staph aureus bacteremia and endovascular infections must be treated with a bactericidal antibiotic, like beta lactams or vancomycin. A new study suggests that bacteriostatic antibiotic, like clindamycin, could be used to treat MRSA bacteremia.

Redeem your CPE or CME credit here!

References and resources: Guthridge I, Smith S, Law M, et al. Efficacy and Safety of Intravenous Lincosamide Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0034321. doi: 10.1128/AAC.00343-21. Epub 2021 Aug 17. PMID: 34125589.


Continuing Education Information:
Learning Objectives:
1. Identify if an uncomplicated patient with MRSA bacteremia may be eligible for bacteriostatic medications
2. Describe some of the advantages of using drugs like clindamycin in these patients

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-339-H01-P
Initial release date: 10/12/21
Expiration date: 10/12/2022
Complete CPE & CME details can be found here !

What's new?

  • GameChangers Pharmacotherapy Podcast will release new episodes on Mondays starting 10/18/2021
  • We are making it easier to claim CE Credit for listening each week! This October - we'll launch a simple, one membership option so you can get one-click CE redemption for GameChangers episodes.  
  • Name changes! You'll notice the podcast show will change to CEimpact - you'll still get new GameChangers episodes released each week on Mondays. Keep listening here and your feed will automatically switch over to CEimpact on 10/18.

Follow CEimpact on Social Media:
LinkedIn
Instagram